Ms. Rosen is a partner in FBC's Corporate Department. Ms. Rosen represents public and private clients in general corporate and securities law matters, with an emphasis on international corporate securities matters and cross-border transactions.
Ms. Rosen counsels clients on various types of Israeli and cross-border transactions, including public and private equity and debt offerings, mergers and acquisitions and venture capital investments.
Ms. Rosen provides ongoing corporate and securities law advice to Israeli companies publicly traded in the United States.
Prior to joining FBC, Ms. Rosen was an associate in the Corporate and Securities Department of Carter Ledyard & Milburn in New York and was a member of its Israeli Practice Group, representing Israeli NASDAQ-listed companies on their U.S. securities law compliance and public and private debt and equity offerings. Prior to that, Ms. Rosen was an associate in the corporate and securities department of a leading Tel Aviv law firm.
Hi-Tech, Technology & Venture Capital
New York, 2005
Hebrew University of Jerusalem, LL.B., 1996
FBC partners, Nitzan Sandor and Sharon Rosen, authored the Israel chapter for the 2019 edition of The Initial Public Offerings Law Review, an annual guide to legal and market developments in each of the most significant jurisdictions worldwide, designed to aid in-house ...Sharon Rosen & Nitzan Sandor | May 2019
FBC represented Clermont Energy Pte. Ltd. in its investment in Eviation Aircraft Ltd., an Israeli company publicly traded in the United States, through a note purchase agreement, pursuant to which Eviation issued to Clermont a convertible promissory note in consideratio...Ronald Lehmann & Sharon Rosen & Dikla Lavy-Fischer & Ariel Mazer & Avia Dallal & Ute Klose-Goldstein | Jan 2019
The Corporate Finance Department at the Israel Securities Authority issued a Staff Legal Bulletin – Dual-listed companies: issuance, reporting, listing and delisting. It is a summary of the most up-to-date information on the issuance, reporting, listing and delisting of...Nitzan Sandor & Sharon Rosen & Ron Sitton | Jan 2019
FBC represented Bristol-Myers Squibb Company (NYSE: BMY) in connection with its $12M equity investment in Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery. The equity offering was made as a private pl...Raz Tepper & Sharon Rosen | Oct 2018
FBC represented J.P. Morgan and Bank of America as Joint Book-Running Managers in the private offering by Wix.com Ltd. (Nasdaq: WIX) of $442.8 million of 0% Convertible Senior Notes due 2023 (including the exercise in full of an over-allotment option granted to the init...Michael Zellermayer & Nitzan Sandor & Anat Shavit & Sharon Rosen & Dikla Nassi | Jul 2018
FBC represented Check-Cap Ltd., listed on NASDAQ, in its $20.2 million follow-on underwritten public offering of units, with each unit consisting of one ordinary share (or ordinary share equivalent) and one Series C warrant to purchase one ordinary share. H.C. Wainwr...Eran Yaniv & Sharon Rosen & Anat Shavit | May 2018
FBC partners, Nitzan Sandor and Sharon Rosen, authored the Israel chapter for the 2018 edition of The Initial Public Offerings Law Review, an annual guide to legal and market developments in each of the most significant jurisdictions worldwide, designed to aid in-house ...Sharon Rosen & Nitzan Sandor | Mar 2018
FBC represented Fiverr International Ltd. and its U.S. subsidiary, Fiverr Inc., in the acquisition of the entire stock capital of And Co Ventures Inc., a Delaware corporation, which develops and markets an application for invoicing, expenses, and paperwork for freelance...Sharon Rosen & Liat Halperin | Jan 2018
FBC represented Frutarom Industries Ltd. in its acquisition of Enzymotec Ltd. (NASD: ENZY), for approximately $210 million, at an equity value of approximately $290 million. Enzymotec is a leading global supplier of specialty lipid-based products and solutions. Prior t...Avraham Well & Sharon Rosen & Anat Shavit & Zohar Liss & Ziv Schwartz & Moran Friedman & Hilla Sachs | Jan 2018
FBC represented Kamada Ltd., listed on NASDAQ and the Tel Aviv Stock Exchange, in its US$15 million follow-on underwritten public offering of its ordinary shares. Kamada also granted the underwriters a 30-day option to purchase additional ordinary shares, for aggregate ...Raz Tepper & Sharon Rosen & Anat Shavit & Nadav Oberman | Aug 2017